How have BEATW shares performed in 2024?

HeartBeam's stock was trading at $0.3990 at the start of the year. Since then, BEATW shares have decreased by 32.3% and is now trading at $0.27. View the best growth stocks for 2024 here .

Are investors shorting HeartBeam?

HeartBeam saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 500 shares, a drop of 80.8% from the March 15th total of 2,600 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is currently 0.1 days. View HeartBeam's Short Interest .

How do I buy shares of HeartBeam?

Shares of BEATW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BEATW

HeartBeam (BEATW) Stock Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Free BEATW Stock Alerts

$0.27

0.00 (0.00%)

(As of 04/24/2024 ET)

Compare

Today's Range: $0.27
▼
$0.27
50-Day Range: $0.17
▼
$0.30
52-Week Range: $0.09
▼
$0.60

Volume: 1,016 shs
Average Volume: 6,087 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get HeartBeam alerts:

Ad Traders Agency

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

About HeartBeam

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

BEATW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BEATW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BEATW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HeartBeam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: NASDAQ:BEATW
CUSIP: N/A
CIK: 1779372
Web: www.heartbeam.com
Phone: 408-899-4443
Fax: N/A
Employees: 15
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Richard M. Ferrari (Age 69)
Exec. Chairman
Comp: $135k
Dr. Branislav Vajdic Ph.D. (Age 68)
Founder, CEO & Director
Comp: $631.64k
Mr. Richard D. Brounstein (Age 73)
CFO & Treasurer
Comp: $329.3k
Mr. Robert P. Eno
Pres
Mr. Kenneth Persen
Chief Technology Officer
Dr. Peter J. Fitzgerald FACC (Age 66)
M.D., Ph.D., Chief Medical Officer

Key Competitors

View All Competitors

BEATW Stock Analysis - Frequently Asked Questions

How have BEATW shares performed in 2024?: HeartBeam's stock was trading at $0.3990 at the start of the year. Since then, BEATW shares have decreased by 32.3% and is now trading at $0.27.
View the best growth stocks for 2024 here.
Are investors shorting HeartBeam?: HeartBeam saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 500 shares, a drop of 80.8% from the March 15th total of 2,600 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is currently 0.1 days.
View HeartBeam's Short Interest.
How do I buy shares of HeartBeam?: Shares of BEATW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BEATW) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial